Literature DB >> 8361100

[Disadvantages of "Gelseal graft" as a vascular prosthesis].

K Yamamoto1, Y Noishiki, M Mo, T Kosuge, M Ishii, Y Ichikawa, K Imoto, J Kondo, A Matsumoto.   

Abstract

In clinical use, the Gelseal Triaxial graft have been shown to have several problems, such as pyrexia, pleural effusion and seroma formation around the graft. To investigate the cause of these complications, we examined mechanical and biological properties of the graft. The water permeability was found to be 0 ml at 120 mmHg in an in vitro study. Scanning electron microscopical observation revealed that gelatin in the graft wall was not uniform and easily detached from the luminal surface. The amount of impregnated gelatin in the graft was found to be 6.73 mg/cm2. In addition, this graft contained 297 and 73 pg endotoxin in extract/g of graft wt at 25 degrees C 72 hrs as assessed by Toxicolor and Endospecy pyrogen tests, respectively. The grafts were implanted in the descending aorta of 8 dogs for 2 weeks in an animal study. Three out of 8 animals died of graft occlusion. Both macroscopic and microscopic evaluations of the explants from 5 dogs showed that neither fibroblasts nor capillary blood vessels had infiltrated in some area of the graft wall. Serous fluid was found to be retained between the graft and the surrounding host tissue in three cases. These results indicated that the Gelseal graft was easy to implant due to zero porosity, but the coated gelatin was not clean and gelatin was easily detachable. Hence, the graft would be prone to some complications such as pyrexia, immune response, thromboembolism, seroma, and pleural effusion. One must be aware of the potential disadvantages of the Gelseal grafts before using it in patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8361100

Source DB:  PubMed          Journal:  Kyobu Geka        ISSN: 0021-5252


  1 in total

1.  Development and physical characteristics of novel zero-porosity vascular graft "triplex(®)".

Authors:  Tetsuro Morota; Shinichi Takamoto
Journal:  Ann Vasc Dis       Date:  2013-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.